Pharma marketing still has a ways to go when it comes to matching itself to our multicultural reality, as we pointed out recently in this piece on diversity and inclusion (and offered some suggestions on how to do it well). Particularly in a country that's increasingly “majority-minority” (Americans age 15
Data breaches have become so common, there’s a Wikipedia page devoted to cataloging them – to date, more than 300 breaches are listed. Types of industries affected include hospitality, travel, internet service providers, banking, social media, retail, and of course, healthcare, among others. The massive Equifax breach announced in September
As we edge closer to the end of 2019, we wanted to stop and smell the roses, or in this case, indulge in a Throwback Thursday moment and share some of our favorite blog posts from this year. This list represents Intouch’s thinking on a range of topics, from the
Artificial intelligence continues to make headlines in a variety of industries, from banking to retail, from wildlife identification to law enforcement, from to sales to telecommunications to healthcare. Just today, Forbes reported that the “AI in the healthcare market worldwide is expected to reach $19.25 billion by 2026, up from
Drug pricing is a hot button issue, including the pricing transparency battle, and it's not going away anytime soon. On July 8, U.S. District Court Judge Amit Mehta ruled that the Department of Health and Human Services had overstepped its authority in requiring pricing disclosures, stating, “That policy very well
Digital Pharma East is just around the corner, and this year’s agenda is jam-packed with valuable content on everything from personalization, to HCP digital targeting, to customer engagement, to business transformation and more. The conference -- held September 17-20 in the heart of Philadelphia -- begins with Digital Future Day
Check out Intouch EVP David Windhausen's thoughts on the potential of voice technology in pharma and healthcare for the Forbes Technology Council.
This POV describes Colorado House Bill 19-1131 and how it could affect pharma marketers. The bill requires that any one-to-one communications between pharmaceutical representatives (or anyone communicating on their behalf) and prescribers must include written information about the wholesale cost of a drug, as well as the names of at least three generic equivalents. The law goes into effect on August 2, 2019.
Harmonious collaboration produces the best work from your agencies, but getting everyone to be on the same page can be a challenge. How do you ensure that everyone’s doing their part? How can you work effectively and efficiently when there are multiple players, multiple meetings and – more than likely